Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas

J Endocrinol Invest. 2023 Nov;46(11):2299-2307. doi: 10.1007/s40618-023-02083-7. Epub 2023 May 7.

Abstract

Purpose: Mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene cause familial isolated pituitary adenomas (FIPA). AIP mutations have also been found in patients with apparently sporadic pituitary adenomas, particularly in young patients with large adenomas. The aim of this study was to determine the frequency of AIP germline mutations in patients with young-onset sporadic pituitary macroadenomas.

Methods: The AIP gene was sequenced in 218 Portuguese patients with sporadic pituitary macroadenomas diagnosed before the age of 40 years.

Results: Heterozygous rare sequence variants in AIP were identified in 18 (8.3%) patients. However, only four (1.8%) patients had pathogenic or likely pathogenic variants. These consisted of two already known mutations (p.Arg81* and p.Leu115Trpfs*41) and two novel mutations (p.Glu246*, p.Ser53Thrfs*36). All four patients had GH-secreting adenomas diagnosed between the ages of 14 and 25 years. The frequency of AIP pathogenic or likely pathogenic variants in patients under the age of 30 and 18 years was 3.4% and 5.0%, respectively.

Conclusion: The frequency of AIP mutations in this cohort was lower than in other studies. Previous reports may have overestimated the contribution of AIP mutations due to the inclusion of genetic variants of uncertain significance. The identification of novel AIP mutations expands the known spectrum of genetic causes of pituitary adenomas and may help understand the role of AIP mutations in the molecular mechanisms underlying pituitary tumorigenesis.

Keywords: AIP; Aryl hydrocarbon receptor interacting protein; Mutation; Pituitary adenoma.

MeSH terms

  • Adenoma* / metabolism
  • Adolescent
  • Adult
  • Germ-Line Mutation
  • Growth Hormone-Secreting Pituitary Adenoma* / genetics
  • Humans
  • Mutation
  • Pituitary Neoplasms* / diagnosis
  • Pituitary Neoplasms* / epidemiology
  • Pituitary Neoplasms* / genetics
  • Young Adult